Atazanavir/Ritonavir and Zinc Pharmacokinetic Study
NCT01475227
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
1 Solvazinc tablet, day 2 to day 15
DRUG:
1 Solvazinc tablet, day 15 to day 28
Sponsor
St Stephens Aids Trust